0172-2748399
help@neurology.com 0172-2748399

Alumni

Dr. Avijit Banik

Nickname: Dr. Avijit Banik
Hometown: Kolkata (Currently in Visakhapatnam) India
Graduate School: PGIMER, Chandigarh
E-mail: avibanik@yahoo.co.in
LinkedIn Profile: https://www.linkedin.com/in/avijit-banik-ph-d-48038416/ Click Here
Current Organization: Dept. of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY, USA
Website: https://bauerhartzlab.org/about-us/

 
Tell briefly about yourself.

I am an ardent scholar of neuroscience and also a socialist to hand over a better world to my next generation.

How was your experience in Neuroscience Research Lab, how did it contribute to your academic or professional development?

My association with NRL was scripted on a bright morning during August 2007 when I met Dr. Akshay at the other side of a conference table for an interview. I came from Bangalore with my couple of years of industry experience after my Masters and wanted to make a mark in a hardcore research laboratory with an absolute aim for the coveted degree, Ph.D. My journey at NRL started as a Senior Research Fellow on 15th of September 2007 and I left NRL for my post-doctoral training on 8th October 2015. In these eight years, I earned my Ph.D. working on the pathophysiology of Alzheimer’s disease (AD) and evaluating the role of umbilical cord blood (UCB) derived stem cells as a potential therapy in AD like mice. I was also trained to manage with research projects and training PhD scholars on the research methodologies. To conclude, NRL has mastered me to deal with the world of academia.

What are your Research interests?

Neurodegeneration, Neuroinflammation, Stem cell biology

What are your current affiliations?

Associate Professor Dept. of Life Sciences GITAM School of Science GITAM (Deemed to be University) Visakhapatnam, AP, India

What was your PhD thesis in or research work? Timeline?

I worked on the pathophysiology of Alzheimer’s disease (AD) and evaluating the role of umbilical cord blood (UCB) derived stem cells as a potential therapy in AD like mice.

GO TO

PAGE